{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-038882","form_type":"8-K","ticker":"GRCE","cik":"0001444192","company_name":"Grace Therapeutics, Inc.","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.448374+00:00","generated_at":"2026-06-04T04:26:59.816595+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Acasti Pharma updates corporate presentation; no material new information disclosed","bullets":["Updated corporate presentation dated April 1, 2024, furnished as Exhibit 99.1.","Presentation covers company overview and NASDAQ listing (ACST).","No financial results, guidance, or operational milestones were announced.","Presentation is available for investor reference on the company's IR page."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-038882","json":"https://secwatch.observer/filing/0000950170-24-038882.json","markdown":"https://secwatch.observer/filing/0000950170-24-038882.md","text":"https://secwatch.observer/filing/0000950170-24-038882.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1444192/000095017024038882/0000950170-24-038882-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1444192/000095017024038882/acst-20240401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:26:59.816595+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}